Tinea Corporis Market Symptoms, Causes, Diagnosis and Treatment Analysis 2027

 Global Tinea Corporis Market is expected to rise steadily at a CAGR of 7.2% during forecast period of 2018-2023.

Tinea corporis is a fungal infection that is caused by tinea rubrum, trichophyton mentagrophytes and epidermophyton floccosum fungi. This fungal infection mainly occurs in humid climatic condition. It is also known as ringworm infection. Tinea corporis infection occurs mostly on arms, legs or can also occur on different parts of body.

The global tinea corporis market is expected to see the growth in upcoming year due to entry of new drug product in market for treatment. Many key players in market are engaged in development of new drug product for tinea corporis treatment.


Tinea corporis is contagious infection which can spread from one person to other hence it is important not to share towel, flannels, bathmats with another person.

Top Industry Key players:

Some of the key players in the global tinea corporis market are

  • Taro Pharmaceuticals. Inc.
  • Teva Pharmaceuticals Inc.
  • Glenmark Pharmaceuticals Inc
  • Breckenridge Pharmaceutical Inc.
  • NorthStar Rx LLC
  • Aurobindo Pharma Limited
  • and Camber Pharmaceuticals Inc.
  • AvKare Inc.
  • Novartis AG
  • Sebela Pharmaceuticals Inc.
  • Bayer AG
  • Blueberry Therapeutics Ltd
  • Perrigo Company.

Market Segmentation:

Global tinea corporis market is segmented into drug type, diagnosis, treatment and end-users.

Global Tinea Corporis Market by Drug Type

  • Antifungals
  • Steroids
  • Anti-Infective Combinations

Global Tinea Corporis Market, by Diagnosis

  • Physical Exam
  • Imaging Tests
    • Wood lamp (black light) examination
    • Microscopy using potassium hydroxide (KOH)
    • Fungal culture
    • Skin biopsy
    • Others

Browse Complete Premium Research Report Enabled with TOC at https://www.marketresearchfuture.com/reports/tinea-corporis-market-6838

Global Tinea Corporis Market, by Treatment

  • Antifungal shampoos
  • Antifungal creams
  • Drugs
  • Others

Global Tinea Corporis Market, by End-Users

  • Hospital Pharmacies
  • Drug Stores
  • Online Pharmacies
  • Dermatology hospitals
  • Others

Regional Market Summary

Geographically, the America holds the highest market share for tinea corporis market and the reason being many market players are engaged in development of new drug product innovation, and as this infection is more prone to humid climatic condition there is an increasing prevalence of fungal infection in this region. Whereas increasing awareness of fungal disease and rising healthcare expenditure by the government are some of the factors responsible for growth of market in this region

Europe is expected to be the second largest market in the globe owing to the increasing aging population, increasing prevalence of fungal infection, focus on aesthetic appearance, increasing research base. Whereas rise in susceptible immune compromised patient population is responsible for market growth in this region.

Asia-Pacific is anticipated to be the fastest growing market owing to the growing prevalence of fungal infection, changing lifestyle, increase in population, increasing healthcare expenditure by government are some of the factor responsible for market growth in this region.

Intended Audience

  • Manufacturers and Suppliers
  • Hospitals and Clinics
  • Laboratories and Associations
  • Research Institutes
  • Dermatology Clinics

About Market Research Future: we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:

Market Research Future

Comments

Post a Comment

Popular posts from this blog

Human Insulin Market Share Estimation, and Size Analysis, Industry Expansion ,Future Trends By 2027

  Human Insulin Market: Information by Type (Traditional Human Insulin (Premixed Traditional, Intermediate Acting and Short-Acting), Modern Human Insulin (Premixed Modern, Long-Acting and Rapid Acting) and Brand (Lantus, Novorapid, Humalog, Novomix, Levemir, Apidar, Humulin and Insuman)) – Forecast till 2027 The human insulin market is estimated at  USD 90,812.40 Million till 2025  and is expected to grow at a CAGR of  12.10%  within forecasted period. GET FREE SAMPLE COPY @  https://www.marketresearchfuture.com/sample_request/951 company profile and country level customization on reports. This report includes a study of strategies, of major market players. It includes the product portfolios, developments of leading major players such as Biocon Ltd. (India), Tonghua Dongbao Pharmaceuticals Co., Ltd. (China), Adocia (France.), Merck & Co. (U.S.), Julphar (UAE), Bristol-Myers Squibb Company (U.S.), GlaxoSmithKline Plc (U.K.), Oramed Pharmaceuticals, Inc. (Israel), Novo Nordisk A/S (D
Read more

Bone Cancer Treatment Market Size Latest Trends and Global Industry Overview 2027

  The neoplastic growth of tissue in bone causes bone tumor. If the abnormal growth of tissue is diagnosed to be malignant, it causes bone cancer. However, the risk of bone cancer triggered due to metastasis or spread of other cancerous tissues from different parts of the body is comparatively high. Increasing prevalence of bone cancer caused due to metastasis is inducing high demand for high-quality treatments, resulting in the expansion of the global bone cancer market. also read @  https://www.medgadget.com/2019/11/bone-cancer-market-global-outlook-by-industry-growth-rate-estimated-size-valuable-share-development-history-current-analysis-and-estimated-forecast-to-2022.html In order to fulfill the skyrocketing demand, the players in the global bone cancer market are increasing their research and development expenditure, which in turn is fueling the expansion of the bone cancer market on a global level. According to the worldwide bone cancer statistics, the survival rate of children a
Read more